Suggestions
Saikat Nandi, Ph.D.
Investor | C-Suite Executive | Board Member
Professional Background
Dr. Saikat Nandi is a distinguished investment executive and entrepreneur with an extensive career spanning over 20 years in the healthcare, technology, and financial services sectors. His remarkable expertise encompasses both buy-side investment management and high-level C-suite operations, allowing him to leverage his considerable skills in a variety of business environments. Throughout his career, Dr. Nandi has managed public and private investments exceeding $1 billion, demonstrating a profound understanding of asset management and strategic growth in complex markets.
In his role as Global Chief Business Officer at Oryzon Genomics SA, Dr. Nandi successfully managed cross-functional teams, fostering collaboration across various sectors including financing, mergers and acquisitions (M&A), business development, and operations. His leadership in these areas has been pivotal in driving business success and establishing Oryzon as a key player in the biotechnology space. Previously, Dr. Nandi also excelled as a Portfolio Manager at AIG Asset Management, where he oversaw AIG’s healthcare and life sciences investments, strategically guiding venture capital, private equity, hedge fund, and debt security endeavors.
Dr. Nandi's impact extends beyond his work in investment management. As a Healthcare Investment Advisor at a renowned global multi-family office, he managed venture and growth equity investments with a special focus on the life sciences sector. His early career included a significant role as a Business Development Consultant at the New York State Center for Biotechnology, where he oversaw strategic partnerships and capital-raising activities, further enhancing his skills in commercialization and startup development.
Education and Achievements
Dr. Nandi achieved his D.Phil. (Ph.D.) in Biochemistry, with a focus on Oncology and Rare Disease, from the prestigious University of Oxford, a testament to his strong academic background and research proficiency. His educational journey has greatly informed his professional endeavors, particularly within the realms of healthcare and biotechnology, where scientific understanding is vital for informed decision-making and successful business operations.
His profound commitment to fostering innovation and supporting emerging talent is evident through his role as a Strategic Advisor and Investment Mentor for New York State Incubator and Vanderbilt University Accelerator. Dr. Nandi has a rich history of serving on the Board of Directors for several notable companies, including Atomwise, Cullinan Oncology (NASDAQ: CGEM), ElevateBio, Fractyl Health, Roivant Sciences (NASDAQ: ROIV), and SQZ (NYSE: SQZ). His contributions to these organizations reflect his ability to guide companies through critical growth phases and operational challenges.
In addition to his business achievements, Dr. Nandi enjoys a Visiting Scientist position at the Cold Spring Harbor Laboratory (CSHL) and actively serves as a reviewer and board member for various portfolio companies, federal funding agencies, scientific journals, and philanthropic organizations. His engagement in these roles highlights his commitment to advancing research and application in areas of significant societal impact.
Notable Achievements
Dr. Nandi's contributions to the fields of biotechnology and investment management have earned him several awards and recognitions, alongside numerous research grants that bolster his efforts in innovative scientific exploration. He has authored over two dozen articles and books, demonstrating his thought leadership in both investment strategies and scientific research. His multilingual capabilities and extensive global experience have further broadened his perspective, enabling him to work effectively in diverse cultural and economic landscapes, including North America, Europe, and Asia.
In addition to his impressive professional credentials, Dr. Nandi is an avid dog lover, showcasing his multifaceted personality and commitment to living a balanced life. His dynamic leadership style, combined with his robust academic knowledge and practical experience, positions him as a highly influential figure in the investment and biotechnology sectors. Dr. Nandi's impressive track record of managing diverse projects and leading successful ventures not only reflects his capabilities in traditional aspects of finance but also his innovative approach to modern healthcare challenges.